We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

The new firm is raising a $150 million fund to back startups around science emerging outside Boston and San Francisco.

This Peninsula biotech company started as a way to find a cancer drug for a co-founder's father. It now layoffs show it’s ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...

Those who graduate from the facility at Passaic County Technical Institute in Wayne will get associate’s degrees in ...

Legend Biotech's valuation is conservative, suggesting potential for significant appreciation and growth ahead. Click here to ...

Biotech Nuvalent unveiled updates on two experimental cancer medicines over the weekend. Analysts say each could be the best ...

Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...